As expected, overexpression of either ZHX2 or p65 increased NF-κB target gene expression and promoted ccRCC cell growth in the absence of drug treatment (Fig. 6A–F). This evidence concerns the gene ZHX2 and nonpapillary renal cell carcinoma.